Bhavik Patel, MD
Hospitalist · Newport News, VANPI 1508177254
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $411 and has fallen 78.6% since, to $88 in 2025. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$140
- Boehringer Ingelheim$112
- Medtronic$88
- Pfizer$70
- Novartis$65
- Amgen$64
- plus $110 from 5 others
Across 2 payments — averaging $13,930 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$28K
What the payments were for
- Food & beverage$649100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 4 | $140 |
| Boehringer Ingelheim | 1 | $112 |
| Medtronic | 1 | $88 |
| Pfizer | 5 | $70 |
| Novartis | 4 | $65 |
| Amgen | 4 | $64 |
| Johnson & Johnson | 2 | $36 |
| Bard Access Systems, Inc. | 1 | $23 |
| AstraZeneca | 1 | $22 |
| AbbVie | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$649 in reported general payments places this provider in the 90th percentile of 539 hospitalist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 19 | $136 |
| ClopidogrelClopidogrel Bisulfate | 12 | $59 |
| Prednisone | 17 | $52 |
| Atorvastatin Calcium | 13 | $51 |
| Amlodipine Besylate | 18 | $33 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Newport News
- Mohammed AmerNewport News$5K
- Neel PatelNewport News$964
- Hardik VoraNewport News$725
- Ivan AlgerNewport News$581
- Nagesh Gollahalli ShivaramaiahNewport News$567
- Ankur PatelNewport News$565
- Yuri MaricichCharlottesville$212K
- Dennis NguyenSpringfield$8K
- Muhammad AfridiWinchester$7K
- Lana WahidRoanoke$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.